Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

A study on the immune response and safety of vaccine against respiratory syncytial virus given to adults 18 to 49 years of age at increased … Ended

2023-510190-34-00 Respiratory Syncytial Virus Infections 5 2024-06-04
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months Ended

2022-502022-41-00 Acute lower respiratory infection 3 2024-05-28
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Val… Ended

2024-511570-77-00 not applicable (submitted trial is a bioavailability st 2 2024-05-13
PH2a, VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living with HIV-1 Ended

2023-507173-18-00 HIV Infections 4 2024-04-09
HIV: Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Ended

2023-505900-53-00 HIV infection 4 2024-04-08
Study in Participants With Normal Kidney Function and Reduced Kidney Function to Test How Kidney Function Can Change What Happens to Obeldes… Ended

2023-504780-17-00 Renal Impairment 3 2024-03-19
Study of B/F/TAF in Participants Switching from CAB + RPV to B/F/TAF for HIV-1 Infection. Ended

2023-506660-13-00 HIV-1 infection 6 2024-03-07
A controlled human rhinovirus infection study of 2-Deoxy-D-Glucose in healthy adults. Ended

2023-509311-91-01 Rhinovirus-associated illness 4 2024-02-15
A randomized, Phase 1b, single-center, observer-blind, active-controlled study to evaluate the safety, immunogenicity, and immunological mec… Ended

2023-508230-33-00 Influenza 3 2024-01-12
A first-in-human phase 1, single center, randomized, double-blind, placebo-controlled study to evaluate the safety and immunogenicity of thr… Ended

2023-506396-94-00 Sarbecovirus diseases 1 2024-01-08
PH2a, VH3739937 Proof-Of-Concept in TN HIV-1 Infected Adults Ended

2023-505780-37-00 HIV Infections 4 2023-12-21
Proof of concept treatment study of orally administered VH4004280 or VH4011499 in HIV-1 infected adults Ended

2023-505350-18-00 HIV Infections 4 2023-12-15
A study on the reactogenicity, safety, immune response, and efficacy of a targeted immunotherapy against HSV in healthy participants aged 18… Ended

2024-510571-37-00 Herpes Simplex 7 2023-12-06
A study to evaluate the efficacy, safety, participant choice and preference of an oral once-daily regimen or a long-acting injectable regim… Ended

2023-503893-19-00 HIV-1 infection 5 2023-12-06
Ph 3b, BIC/FTC/TAF to DTG/3TC FDC, 96 Week switch, efficacy, safety, and tolerability study in ART-experienced older adults living with HIV … Ended

2022-503137-66-00 Human immunodeficiency virus (HIV) 5 2023-11-29
A trial to learn if different doses of REGN17092 are safe in healthy adults Ended

2023-505041-52-00 SARS-CoV-2 (COVID-19) 1 2023-11-28
ITPP as an adjunctive treatment for progressive respiratory failure in COVID-19 and other pulmonary parenchymal infections [BREATH2] Ended

2024-517878-21-00 COVID-19 and other pulmonary parenchyma infections. 4 2023-11-28
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized… Ended

2023-504487-41-00 COVID-19 5 2023-11-28
A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredients Ended

2023-506442-24-00 coronavirus disease 2019 3 2023-11-15
A clinical study of MK-8527 in people with HIV-1 (MK-8527-004) Ended

2023-503682-39-00 HIV-1 (Human Immunodeficiency Virus Type 1) 3 2023-11-13
A Phase IIb/III, Double-Blind, Randomised, Active-Controlled, Multi-Center, Non-Inferiority Clinical Trial, to assess the safety and immunog… Ended

2023-508458-25-00 COVID-19 disease 10 2023-11-13
A study on the immune response and safety of an RSV vaccine when given to adults 18 years of age and above who received lung or kidney trans… Ended

2023-503951-81-00 Respiratory Syncytial Virus Infections 4 2023-11-07
The Celljuvant study, A phase 3 Immunogenicity and Safety Study of aQIVc HD Vaccine in Adults aged 50 years and older. Ended

2023-503763-42-00 Healthy individuals or individuals with stable comorbid 5 2023-11-03
A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Intervention Called Sisunatovir in Healthy Adults Ended

2023-507116-12-00 RSV 3 2023-10-25